Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 36% ± 12% | |
plasmacytoid dendritic cell | 8 studies | 23% ± 7% | |
endothelial cell | 5 studies | 25% ± 8% | |
epithelial cell | 5 studies | 36% ± 13% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 16% ± 0% | |
classical monocyte | 4 studies | 22% ± 5% | |
retinal ganglion cell | 4 studies | 52% ± 30% | |
deuterosomal cell | 3 studies | 19% ± 5% | |
non-classical monocyte | 3 studies | 24% ± 3% | |
CD8-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
plasma cell | 3 studies | 28% ± 11% | |
retina horizontal cell | 3 studies | 27% ± 12% | |
macrophage | 3 studies | 21% ± 3% | |
B cell | 3 studies | 19% ± 3% | |
natural killer cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1716.95 | 21 / 21 | 100% | 43.78 | 504 / 504 |
kidney | 100% | 2077.29 | 89 / 89 | 100% | 35.12 | 901 / 901 |
liver | 100% | 1162.96 | 226 / 226 | 100% | 31.97 | 406 / 406 |
ovary | 100% | 1224.94 | 180 / 180 | 100% | 48.67 | 430 / 430 |
prostate | 100% | 1898.50 | 245 / 245 | 100% | 47.84 | 502 / 502 |
stomach | 100% | 1728.96 | 359 / 359 | 100% | 37.18 | 286 / 286 |
thymus | 100% | 2036.26 | 653 / 653 | 100% | 58.44 | 605 / 605 |
brain | 100% | 3037.86 | 2641 / 2642 | 100% | 68.58 | 705 / 705 |
skin | 100% | 1107.71 | 1807 / 1809 | 100% | 44.42 | 472 / 472 |
intestine | 100% | 1893.23 | 966 / 966 | 100% | 42.23 | 526 / 527 |
uterus | 100% | 1414.26 | 170 / 170 | 100% | 37.69 | 458 / 459 |
lung | 100% | 1602.08 | 577 / 578 | 100% | 34.21 | 1154 / 1155 |
adrenal gland | 100% | 1938.25 | 258 / 258 | 100% | 54.40 | 229 / 230 |
breast | 100% | 1480.02 | 459 / 459 | 100% | 46.97 | 1113 / 1118 |
esophagus | 100% | 1811.31 | 1445 / 1445 | 99% | 20.98 | 182 / 183 |
pancreas | 100% | 1243.91 | 328 / 328 | 99% | 35.74 | 177 / 178 |
adipose | 100% | 1411.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 24.41 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 66.21 | 29 / 29 |
muscle | 100% | 2299.83 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1916.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.05 | 1 / 1 |
blood vessel | 100% | 1646.62 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1574.76 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1299.91 | 842 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051881 | Biological process | regulation of mitochondrial membrane potential |
GO_0070945 | Biological process | neutrophil-mediated killing of gram-negative bacterium |
GO_2000377 | Biological process | regulation of reactive oxygen species metabolic process |
GO_0032700 | Biological process | negative regulation of interleukin-17 production |
GO_0006954 | Biological process | inflammatory response |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0048469 | Biological process | cell maturation |
GO_0001779 | Biological process | natural killer cell differentiation |
GO_0006909 | Biological process | phagocytosis |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | TUSC2 |
Protein name | Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2) Tumor suppressor 2, mitochondrial calcium regulator (Tumor suppressor candidate 2, isoform CRA_b) Tumor suppressor 2, mitochondrial calcium regulator |
Synonyms | hCG_2039470 LGCC PDAP2 C3orf11 FUS1 |
Description | FUNCTION: May function as a tumor suppressor, inhibiting colony formation, causing G1 arrest and ultimately inducing apoptosis in homozygous 3p21.3 120-kb region-deficient cells. |
Accessions | O75896 ENST00000421918.1 ENST00000232496.5 G3V0I0 F2Z2A9 ENST00000417867.1 ENST00000454201.5 |